CClinicalTrials.gg
RecruitingNCT07237139INSPIREUpdated Dec 9, 2025

Pulmonary Volume Changes During Synchonized Noninvasive Positive Pressure Ventilation

An observational study in Infant, Preterm, Respiratory Distress Syndrome (Neonatal) and Chronic Lung Disease of Newborn, sponsored by University of Zurich. Recruiting at 1 site in Switzerland. Open to participants aged Up to 4 Weeks. Per ClinicalTrials.gov, last updated 2025-12-09.

Sponsored by University of Zurich · Observational

From the registry’s dates

  • Started Nov 2025; still recruiting 10 months later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
27
Ages
Up to 4 Weeks
Sex
All
01

Study summary

Current evidence suggests that noninvasive positive pressure ventilation (NIPPV) is more effective than continuous positive airway pressure (CPAP) in preventing respiratory failure in preterm infants with respiratory distress syndrome (RDS), both as initial and post-extubation support. NIPPV may be delivered in synchronized (sNIPPV) or non-synchronized (nsNIPPV) modes, with sNIPPV offering clear benefits by coordinating support with the infant's own breathing. Recent studies indicate sNIPPV is superior to nsNIPPV in preventing respiratory failure, though the intrapulmonary mechanisms behind this advantage remain unclear. To address this, the present study uses Electrical Impedance Tomography (EIT) to evaluate how lung volume changes during different types of breaths and ventilator inflations - spontaneous breaths, synchronized inflations, non-synchronized inflations, and backup inflations - in preterm infants receiving sNIPPV.

Read the detailed description

Hypothesis:

Synchronized inflations during NIPPV will increase tidal volumes (VT) and lung aeration when compared with non-synchronized inflations. Pressure peaks delivered during expiration (non-synchronized inflations), between spontaneous breaths (backup inflations), or during periods of apnea (backup inflations) will not increase relative VT.

Primary objective:

The primary objective is to assess lung volume changes between spontaneous breaths and synchronized inflations, non-synchronized inflations, and backup inflations using EIT.

Secondary objectives:

The secondary objectives are to assess regional differences in aeration and ventilation among spontaneous breaths, synchronized inflations, non-synchronized inflations, and backup inflations using EIT.

Primary endpoint:

Difference in relative Vt (rel. Delta-Z) between spontaneous breaths and synchronized inflations.

Study procedures:

Study procedures include attaching an EIT belt and a pulse oximeter sensor during the final nursing care session before the study begins. Synchronized NIPPV is provided by EVEneo ventilators, and synchronization will be achieved through an abdominal capsule (Graseby).

  1. Sixty minutes after the beginning of the EIT recording , the noninvasve ventilation mode will be switched to CPAP for 2 minutes. This 2-minute period will be the baseline period during which spontaneous breathing will be assessed.
  2. The NIV mode will then be switched back to sNIPPV. Ventilator settings will be maintained at the same levels used before the start of the study, and adjustments will not be permitted.
  3. Prior to the next nursing care session, a second 2-minute nCPAP period will be introduced and serve as the baseline (together with the 1st CPAP period) .
  4. The EIT recording and SpO2/HR measurements will continue until the next nursing care round, at which point the EIT belt and SpO2 sensor will be removed.
02

Conditions studied

  • Infant, Preterm
  • Respiratory Distress Syndrome (Neonatal)
  • Chronic Lung Disease of Newborn
  • Respiratory Support
  • Synchronized Noninvasive Positive Pressure Ventilation (SNIPPV)
  • Lung Volume

Keywords

  • Synchronized noninvasive positive pressure ventilation (SNIPPV)
  • Lung volume
  • Electrical Impedance Tomography (EIT)
  • infant, preterm
03

In context

Premature Birth

2,554 studies on the registry are indexed under Premature Birth; 498 are open to participants now.

This study's planned enrollment of 27 is below the median of 112 across 777 observational studies indexed under Premature Birth.

Browse Premature Birth studies →

Lead sponsor

University of Zurich is the lead sponsor of 1,030 studies on the registry; 130 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Up to 4 Weeks
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

This study will take place at the Department of Neonatology of the University Hospital Zurich. Preterm infants on a synchronized mode of non-invasive positive pressure ventilation will be screened for eligibility and parents will be approached by the treating physician or a clinician-researcher who is authorized to access the patient's clinical data.

Inclusion criteria

  • Written informed consent by one or both parents or legal guardians
  • Gestational age at birth \< 30 0/7 weeks
  • Infants on sNIPPV respiratory support
  • Below 4 weeks chronological age

Exclusion criteria

Exclusion Criteria:

  • Severe congenital malformation adversely affecting lung aeration or perfusion (e.g., congenital heart defects)
  • Too ill/unstable in the opinion of the treating physician.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
27 participants (estimated)
Patient registry
No

Groups and cohorts

  • Preterm infants with a gestational age < 30 0/7 weeks at birth

    Infants on sNIPPV respiratory support and below 4 weeks chronological age

    Device: Electrical Impedance Tomography (EIT)

Interventions

  • DeviceElectrical Impedance Tomography (EIT)

    Electrical Impedance Tomography and clinical data will be recorded continuously. Corresponding data will be extracted and analyzed at five pre-defined timepoints.

06

What researchers measure

Primary outcomes

  1. Tidal volume (VT)

    Difference in relative VT (rel. ΔZ) between spontaneous breaths and synchronized inflations.

    Time frame: At five pre-defined timepoints from the beginning to the end of the study at 180 minutes.

Secondary outcomes

  1. Global lung impedance

    Difference between end-expiratory lung impedance (EELI) and inspiratory onset lung impedance (SILI) during spontaneous breaths, synchronized inflations, non-synchronized inflations, and back-up inflations.

    Time frame: At five pre-defined timepoints from the beginning to the end of the study at 180 minutes.

  2. Regional tidal volume distribution

    Difference in regional tidal distribution between spontaneous breaths, synchronized inflations, non-synchronized inflations and back-up inflations

    Time frame: At five pre-defined timepoints from the beginning to the end of the study at 180 minutes.

  3. Center of ventilation

    Difference in center of ventilation between spontaneous breaths, synchronized inflations, non-synchronized inflations and back-up inflations

    Time frame: At five pre-defined timepoints from the beginning to the end of the study at 180 minutes.

  4. Silent spaces

    Difference in silent spaces between spontaneous breaths, synchronized inflations, non-synchronized inflations and back-up inflations

    Time frame: At five pre-defined timepoints from the beginning to the end of the study at 180 minutes.

  5. Global inhomogeneity index

    Difference in global inhomogeneity index between spontaneous breaths, synchronized inflations, non-synchronized inflations and back-up inflations. An inhomogeneity index of zero represents a perfectly homogeneous distribution of ventilation.

    Time frame: At five pre-defined timepoints from the beginning to the end of the study at 180 minutes.

  6. Coefficient of variation

    Difference in coefficient of variation (EIT) between spontaneous breaths, synchronized inflations, non-synchronized inflations and back-up inflations

    Time frame: At five pre-defined timepoints from the beginning to the end of the study at 180 minutes.

  7. Inspiratory time

    Difference in inspiratory times between spontaneous breaths, synchronized inflations, non-synchronized inflations and back-up inflations

    Time frame: At five pre-defined timepoints from the beginning to the end of the study at 180 minutes.

  8. Expiratory time

    Difference in expiratory times between spontaneous breaths, synchronized inflations, non-synchronized inflations and back-up inflations

    Time frame: At five pre-defined timepoints from the beginning to the end of the study at 180 minutes.

  9. Lung ultrasound score

    Difference in lung ultrasound score at two pre-defined timepoints. Each lung will be divided into 3 areas. For each lung area, a 0- to 3-point score will be given (total score ranging from 0-18). Higher scores represent greater severity of lung disease.

    Time frame: Immediately before the first infant handling as well as following electrical impedance tomography belt removal.

  10. Heart rate

    Changes of heart rate between five pre-defined time points.

    Time frame: Continuous measurement during the 180-minute recording period.

  11. Peripheral oxygen saturation

    Changes in oxygen saturation between five pre-defined time points.

    Time frame: Continuous measurement during the 180-minute recording period.

  12. Oxygen supplementation

    Changes in FiO2 between five pre-defined time points.

    Time frame: Continuous measurement during the 180-minute recording period.

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 9, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07237139
Lead sponsor
University of Zurich
Collaborators
University Hospital, Zürich
Responsible party
Sponsor
First posted
Nov 19, 2025
Start date
Nov 17, 2025
Primary completion
Dec 31, 2026 (estimated)
Completion
Jan 30, 2027 (estimated)
Last update
Dec 9, 2025

Study contacts

Christoph M Rüegger, MD
Contact
christoph.rueegger@usz.ch
+41432539810
Claudia Knöpfli
Contact
claudia.knoepfli@usz.ch
+41442555340
Vincenzo Cannizzaro, MD
study chair · Newborn Research, Department of Neonatology, University Hospital and University of Zurich, Zurich, Switzerland

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion